Dyne Therapeutics, Inc. (DYN) NASDAQ
18.84
+0.74(+4.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
18.84
+0.74(+4.09%)
Currency In USD
| Market Cap | 2.51B |
| Enterprise Value | 1.64B |
| P/E Ratio | -5.42 |
| PEG Ratio | -1.65 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.49 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.38 |
| Return On Equity | -0.61 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.05M |
| EBITDA | -437.97M |
| Net Income | -446.21M |
| Diluted EPS | -3.47 |
| Total Cash | 1.11B |
| Total Cash/Share | 8.65 |
| Total Debt | 20.28M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 22.25 |
| Book Value Per Share | 7.57 |
| 52-Week Change | 100 |
| 52-Week High | 25 |
| 52-Week Low | 6.36 |
| Moving Average 50 Days | 17.16 |
| Moving Average 200 Days | 15.59 |
| Average Volume | 2.24M |
| Shares Outstanding | 165.03M |
| % Held by Institutions | 125.47 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |